Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sayeh Mottaghi & Hassan Abbaszadeh. (2022) Natural Lignans Honokiol and Magnolol as Potential Anticarcinogenic and Anticancer Agents. A Comprehensive Mechanistic Review. Nutrition and Cancer 74:3, pages 761-778.
Read now
Read now
Zeen Tong, Allison Gaudy, Daniel Tatosian, Francisco Ramirez-Valle, Hong Liu, Jian Chen, Matthew Hoffmann & Sekhar Surapaneni. (2021) Assessment of drug-drug interactions of CC-90001, a potent and selective inhibitor of c-Jun N-terminal kinase. Xenobiotica 51:12, pages 1416-1426.
Read now
Read now
Zeen Tong, Rangaraj Narayanan, Christian Atsriku, Jim Nissel, Yan Li, Hong Liu, Xiaomin Wang & Sekhar Surapaneni. (2019) Assessment of drug–drug interaction potential and PBPK modeling of CC-223, a potent inhibitor of the mammalian target of rapamycin kinase. Xenobiotica 49:1, pages 54-70.
Read now
Read now
Cong Xu, Mengyue Luo, Huidi Jiang, Lushan Yu & Su Zeng. (2015) Involvement of CAR and PXR in the transcriptional regulation of CYP2B6 gene expression by ingredients from herbal medicines. Xenobiotica 45:9, pages 773-781.
Read now
Read now
Articles from other publishers (1)
Jing Li, Ming-rui Li, Bao Sun, Cheng-ming Liu, Jing Ren, Wen-qian Zhi, Pei-yu Zhang, Hai-ling Qiao & Na Gao. (2019) Inhibition of Rat CYP1A2 and CYP2C11 by Honokiol, a Component of Traditional Chinese Medicine. European Journal of Drug Metabolism and Pharmacokinetics 44:6, pages 787-796.
Crossref
Crossref